Which Is the Better Buy: Vanguard's Total World ETF or iShares' Emerging Markets EEM?

The important read-through is not about these two products as securities; it is about marginal capital allocation. If investors keep preferring the lowest-friction global-beta wrapper, the winner is the handful of mega-cap operating businesses that dominate broad indices, while the “EM growth” basket becomes a more expensive way to own a much narrower, more cyclical set of balance sheets. That mechanically favors NVDA, AAPL, and MSFT in passive sleeves, but leaves TSM/SSNLF/SKHYV more exposed to swings in single-region sentiment rather than steady allocator demand.

Second-order, the fee gap matters most in retirement-plan and advisor model flows, where a 60-70 bps spread compounds into persistent share-creation advantage over 1-3 years. That does not change fundamentals overnight, but it can widen valuation support for VT constituents and compress the relative multiple of EM benchmarks if flows remain passive and benchmark-aware. The converse is also true: if the dollar rolls over or China/Korea semiconductor cycle re-accelerates, EEM can outperform sharply because its beta is more concentrated and its top weights have higher operating leverage.

Contrarian view: consensus may be over-indexing on the backward-looking return gap and underestimating regime change risk. EEM’s lower drawdown history can flip quickly in a soft-USD / stimulus-led EM rally, while VT is still effectively a high-foreign-revenue, US mega-cap concentration trade in disguise. Falsifiers are clear: a sustained DXY move lower, credible China credit impulse, or a breakout in EM earnings revisions would weaken the structural case for preferring VT as the default allocation.